Detalhe da pesquisa
1.
RNF20 contributes to epigenetic immunosuppression through CDK9-dependent LSD1 stabilization.
Proc Natl Acad Sci U S A
; 121(7): e2307150121, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315842
2.
The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy.
BMC Cancer
; 24(1): 13, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166846
3.
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
BMC Med
; 21(1): 493, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38087296
4.
Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer.
Cancer Cell Int
; 23(1): 83, 2023 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120513
5.
PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China.
World J Surg Oncol
; 21(1): 296, 2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723497
6.
Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer.
FASEB J
; 35(4): e21531, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33769605
7.
Preoperative tumor biopsy results in more detected sentinel nodes than intraoperative biopsy in breast cancer patients.
World J Surg Oncol
; 18(1): 178, 2020 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32693797
8.
[Effect of recombinant human p53 adenovirus (Ad-p53) combined with EGFR inhibitor gefitinib on the sensitivity of breast cancer MDA-MB-468 cells].
Zhonghua Zhong Liu Za Zhi
; 36(12): 886-91, 2014 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-25623760
9.
SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
J Proteomics
; 292: 105055, 2024 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040194
10.
Efficacy and safety of disitamab vedotin after trastuzumab for HER2 positive breast cancer: a real-world data of retrospective study.
Am J Cancer Res
; 14(2): 869-879, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38455400
11.
Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study.
Clin Breast Cancer
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729821
12.
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.
Clin Transl Med
; 14(5): e1687, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38738791
13.
Prediction of bone metastasis risk of early breast cancer based on nomogram of clinicopathological characteristics and hematological parameters.
Front Oncol
; 13: 1136198, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37519779
14.
A safety assessment model of filling mining based on comprehensive weighting-set pair analysis.
Environ Sci Pollut Res Int
; 30(21): 60746-60759, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041354
15.
Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway.
Sci Rep
; 13(1): 1384, 2023 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36697441
16.
Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China.
Front Oncol
; 13: 1136380, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404769
17.
FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination.
Mol Cancer Res
; 21(12): 1303-1316, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540490
18.
A novel nomogram model of breast cancer-based imaging for predicting the status of axillary lymph nodes after neoadjuvant therapy.
Sci Rep
; 13(1): 5952, 2023 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37045864
19.
A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local-Regional Recurrence After Breast-Conserving Therapy.
Front Oncol
; 12: 861210, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35928880
20.
The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China.
Technol Cancer Res Treat
; 20: 15330338211037812, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342244